PCSK6 and inflammatory bowel disease: For instances, in inflammatory bowel disease (IBD) research, proprotein convertase subtilisin/kexin type (PCSK6) has been implicated in increasing the proportions of Th1 cells and M1 macrophages (58), both of which are critical for effective immunotherapy.